Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines.

[1]  L. S. Adelman Grading astrocytomas. , 1994, Neurosurgery clinics of North America.

[2]  T. Mäkelä,et al.  Alternative mRNA forms and open reading frames of the max gene. , 1993, Oncogene.

[3]  R. DePinho,et al.  Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. , 1992, Genes & development.

[4]  C. James,et al.  Molecular genetic characterization of CNS tumor oncogenesis. , 1992, Advances in cancer research.

[5]  S. Knuutila,et al.  Expression of L-myc and N-myc proto-oncogenes in human leukemias and leukemia cell lines. , 1991, Blood.

[6]  M. Schwab,et al.  The N‐Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. , 1991, The EMBO journal.

[7]  A. Rustgi,et al.  Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product , 1991, Nature.

[8]  G. Prendergast,et al.  Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation , 1991, Cell.

[9]  F. Alt,et al.  myc family oncogenes in the development of normal and neoplastic cells. , 1991, Advances in cancer research.

[10]  L. Neckers,et al.  Antisense suppression of N-myc expression inhibits the transdifferentiation of neuroectoderm tumor cell lines. , 1991, Progress in clinical and biological research.

[11]  R. Eisenman,et al.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. , 1991, Science.

[12]  R. Eisenman,et al.  New light on Myc and Myb. Part I. Myc. , 1990, Genes & development.

[13]  C. Welter,et al.  The cellular myb oncogene is amplified, rearranged and activated in human glioblastoma cell lines. , 1990, Cancer letters.

[14]  B. Gallie,et al.  Mechanism of oncogenesis in retinoblastoma. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[15]  M. Rosenblum,et al.  Patterns of proto‐oncogene expression in human glioma cell lines , 1989, Journal of neuroscience research.

[16]  K. Alitalo,et al.  Oncogene expression in small‐cell lung cancer cell lines and a testicular germ‐cell tumor: Activation of the N‐myc gene and decreased RB mRNA , 1989, International journal of cancer.

[17]  Z. D. Sharp,et al.  Proto-oncogene analyses in brain tumors. , 1989, Journal of neurosurgery.

[18]  K. Alitalo,et al.  The N-myc proto-oncogene and IGF-II growth factor mRNAs are expressed by distinct cells in human fetal kidney and brain , 1989, The Journal of cell biology.

[19]  P. Kelly,et al.  Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.

[20]  R. Makuch,et al.  myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. , 1988, Cancer research.

[21]  B. Vogelstein,et al.  Gene Amplification in Malignant Human Gliomas: Clinical and Histopathologic Aspects , 1988, Journal of neuropathology and experimental neurology.

[22]  D. Paulin,et al.  Nucleotide sequence of the human vimentin gene and regulation of its transcription in tissues and cultured cells. , 1988, Gene.

[23]  J. Battey,et al.  Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing , 1988, Molecular and cellular biology.

[24]  D. Nelson,et al.  The human mid‐size neurofilament subunit: a repeated protein sequence and the relationship of its gene to the intermediate filament gene family. , 1987, The EMBO journal.

[25]  M. Schwab,et al.  Expression of N-myc and c-src during the development of fetal human brain. , 1987, Cancer research.

[26]  K. Alitalo,et al.  myc oncogenes: activation and amplification. , 1987, Biochimica et biophysica acta.

[27]  E. Vuorio,et al.  Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization , 1987, The Journal of cell biology.

[28]  S. Baylin,et al.  Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. , 1986, Science.

[29]  J. Battey,et al.  Human small-cell lung cancers show amplification and expression of the N-myc gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Feinberg,et al.  Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Battey,et al.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer , 1985, Nature.

[32]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[33]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[34]  F. Alt,et al.  Activated expression of the N-myc gene in human neuroblastomas and related tumors. , 1984, Science.

[35]  M Schwab,et al.  Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[36]  U. Pettersson,et al.  Rapid and quantitative recovery of DNA fragments from gels by displacement electrophoresis (isotachophoresis). , 1984, Biochimica et biophysica acta.

[37]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.

[38]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[39]  L. Rorke,et al.  The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. , 1983, Journal of neuropathology and experimental neurology.

[40]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.